Pharmacokinetics and peritoneal penetration of moxifloxacin in peritonitis
- PMID: 16895940
- DOI: 10.1093/jac/dkl305
Pharmacokinetics and peritoneal penetration of moxifloxacin in peritonitis
Abstract
Objectives: To investigate the penetration of moxifloxacin into peritoneal exudate in patients with complicated intra-abdominal infections (cIAIs).
Patients and methods: Patients (n = 10) with evidence of peritonitis who required surgery with drainage of the abdominal cavity received a single intravenous infusion of moxifloxacin, 400 mg, over 1 h. Plasma and peritoneal exudate samples were obtained over 24 h, and moxifloxacin concentrations were measured by HPLC with fluorescence detection.
Results: Plasma moxifloxacin concentrations decreased from a geometric mean of 3.61 mg/L at 1 h to 0.36 mg/L at 24 h. Concentrations in peritoneal exudate were highest 2 h after the start of the infusion, reaching a geometric mean of 3.32 mg/L, and declined to a geometric mean of 0.69 mg/L at 24 h. The exudate/plasma concentration ratio rose from 1.45 at 2 h to 1.91 at 24 h; the 95% confidence intervals for the ratio excluded unity at all time points, suggesting that moxifloxacin penetrates and accumulates in peritoneal exudate. The area under the concentration-time curve (AUC) tended to be greater in exudate; the time to peak concentrations (T(max)) was longer in exudate than in plasma, as were half-life and mean residence time (MRT).
Conclusions: Following intravenous administration, moxifloxacin penetrated peritoneal exudate in patients with peritonitis, achieving and maintaining concentrations that exceed the MICs for pathogens commonly isolated in cIAIs. These findings support the clinical use of moxifloxacin as treatment for cIAIs.
Similar articles
-
Single- and multiple-dose pharmacokinetics of intravenous moxifloxacin in patients with severe hepatic impairment.J Antimicrob Chemother. 2008 Sep;62(3):575-8. doi: 10.1093/jac/dkn212. Epub 2008 May 30. J Antimicrob Chemother. 2008. PMID: 18515790
-
Pharmacokinetics and milk penetration of moxifloxacin after intramuscular administration to lactating goats.Vet J. 2007 Mar;173(2):452-5. doi: 10.1016/j.tvjl.2005.11.003. Epub 2005 Dec 27. Vet J. 2007. PMID: 16377219 Clinical Trial.
-
Penetration of moxifloxacin into bone in patients undergoing total knee arthroplasty.J Antimicrob Chemother. 2006 May;57(5):950-4. doi: 10.1093/jac/dkl091. Epub 2006 Mar 21. J Antimicrob Chemother. 2006. PMID: 16551691 Clinical Trial.
-
Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans.Surv Ophthalmol. 2005 Nov;50 Suppl 1:S32-45. doi: 10.1016/j.survophthal.2005.07.001. Surv Ophthalmol. 2005. PMID: 16257309 Review.
-
Clinical update on the use of moxifloxacin in the treatment of community-acquired complicated intraabdominal infections.Surg Infect (Larchmt). 2010 Oct;11(5):487-94. doi: 10.1089/sur.2009.062. Surg Infect (Larchmt). 2010. PMID: 20583956 Review.
Cited by
-
Newer antibiotics for the treatment of peritoneal dialysis-related peritonitis.Clin Kidney J. 2016 Aug;9(4):616-23. doi: 10.1093/ckj/sfw059. Epub 2016 Jul 4. Clin Kidney J. 2016. PMID: 27478608 Free PMC article.
-
Delafloxacin: design, development and potential place in therapy.Drug Des Devel Ther. 2017 Mar 20;11:881-891. doi: 10.2147/DDDT.S106071. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28356714 Free PMC article. Review.
-
Optimal Clinical Doses of Faropenem, Linezolid, and Moxifloxacin in Children With Disseminated Tuberculosis: Goldilocks.Clin Infect Dis. 2016 Nov 1;63(suppl 3):S102-S109. doi: 10.1093/cid/ciw483. Clin Infect Dis. 2016. PMID: 27742641 Free PMC article.
-
Gender analysis of moxifloxacin clinical trials.J Womens Health (Larchmt). 2014 Jan;23(1):77-104. doi: 10.1089/jwh.2012.4171. Epub 2013 Nov 1. J Womens Health (Larchmt). 2014. PMID: 24180298 Free PMC article. Review.
-
Pharmacokinetics, Safety, and Tolerability of Single-Dose Intravenous Moxifloxacin in Pediatric Patients: Dose Optimization in a Phase 1 Study.J Clin Pharmacol. 2019 May;59(5):654-667. doi: 10.1002/jcph.1358. Epub 2019 Jan 25. J Clin Pharmacol. 2019. PMID: 30681729 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical